This inventor holds 2 USPTO granted patents. Top assignee: Fairhaven Health, LLC. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Innovations in Male Fertility Therapy by Amos N Grunebaum
Introduction
Amos N Grunebaum is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of male fertility therapy, holding a total of 2 patents. His work focuses on developing nutritional supplements aimed at enhancing male reproductive health.
Latest Patents
Grunebaum's latest patents include a composition and method for fertility therapy using nutritional supplements. One embodiment of this invention comprises Lepidium meyenii, carnitine, and Coenzyme Q10. When administered to males following the recommended therapeutic regimen, this composition has been shown to enhance sperm count, sperm quality, and sperm motility. Another patent describes a similar composition that utilizes L-carnitine and Coenzyme Q10, also aimed at improving male fertility outcomes.
Career Highlights
Grunebaum is associated with Fairhaven Health, LLC, where he continues to innovate in the field of fertility therapy. His dedication to improving male reproductive health through scientific research and development has positioned him as a notable figure in this area.
Collaborations
Grunebaum collaborates with Kelly Andrews, contributing to the advancement of fertility therapies through their combined expertise.
Conclusion
Amos N Grunebaum's work in developing nutritional supplements for male fertility therapy showcases his commitment to enhancing reproductive health. His innovative patents reflect a significant step forward in addressing male fertility issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile